2026 ICD-10-CM Diagnosis Code R97.0Elevated carcinoembryonic antigen [CEA]
ICD-10-CM Codes›R00–R99›R97›R97
- Billable — Valid for Submission
- Not Chronic
R97.0 is a billable ICD-10-CM diagnosis code for elevated carcinoembryonic antigen [CEA]. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 947 through 948. As a symptom code, it should not be used as a principal diagnosis once a related definitive diagnosis has been established. Coders also document this condition as high carcinoembryonic antigen level. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Abnormal findings without diagnosis.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- High carcinoembryonic antigen level
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- carcinoembryonic antigen [CEA] - R97.0
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Elevated, elevation
- carcinoembryonic antigen [CEA]
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
CEA Test
CEA stands for carcinoembryonic antigen. CEA is a protein that is a type of "tumor marker." Tumor markers are substances that are often made by cancer cells or by normal cells in response to cancer.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert R97.0 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About R97.0Overview
Is R97.0 (Abnormal tumor markers) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report elevated carcinoembryonic antigen [CEA] on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does R97.0 group to?
When elevated carcinoembryonic antigen [CEA] is the principal diagnosis on an inpatient stay, it groups to MS-DRG 947, 948, with relative weights from 0.8005 to 1.2694 depending on complications. Higher weights mean higher Medicare reimbursement.
Can R97.0 be a principal diagnosis?
Use it with care. This is a symptom code, so once a definitive diagnosis explaining the elevated carcinoembryonic antigen [CEA] is established, that condition takes the principal position instead.
What is the ICD-9 equivalent of R97.0?
Under the General Equivalence Mappings, elevated carcinoembryonic antigen [CEA] converts to ICD-9-CM 795.81 (elev ca-embryoic antigen). The mapping is a direct match.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
